a month ago
CORT
AnalystsEdward NashEdward Nash's Stock Forecasts
AnalystsEdward Nash
Sectors:
Analyst Ranking
Bottom 18%
#3594 out of 4337 analysts
Average Return
-2.72%
Win Rate
40%16 out of 40
Risk vs Reward
Poor
Good
Edward Nash's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ventyx Biosciences IncVTYX | +148.19% | $13.57 | $33.68 | 2022-03-31 - 2023-03-30 | Strong Buy |
Verona Pharma PLCVRNA | +137.90% | $5.25 | $12.49 | 2021-11-12 - 2022-11-11 | Strong Buy |
Amryt Pharma PLCAMYT | +92.60% | $7.57 | $14.58 | 2022-09-06 - 2023-01-10 | Strong Buy |
Theratechnologies IncTHTX | +87.50% | $7.68 | $14.40 | 2020-04-15 - 2021-04-15 | Strong Buy |
Uniqure NvQURE | +80.80% | $34.84 | $62.99 | 2018-05-24 - 2019-05-24 | Strong Buy |
Edward Nash Analyst Color
Get additional color on Edward Nash's coverage of popular stocks
4 months ago
CRDL
4 months ago
AKRO
6 months ago
AKRO
8 months ago
VTYX
8 months ago
TVTX
a year ago
VTYX
2 years ago
VRNA
Edward Nash's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verona Pharma PLCVRNA | 3 | Strong Buy | $35.00 | +111.35% | Reiterates | a month ago |
Corcept Therapeutics IncCORT | 2 | Strong Buy | $35.00 | +8.29% | Maintains | a month ago |
Intercept Pharmaceuticals IncICPT | 6 | Strong Buy | $20.00 | +91.57% | Maintains | 2 months ago |
Travere Therapeutics IncTVTX | 5 | Strong Buy | $35.00 | +334.78% | Maintains | 2 months ago |
Madrigal Pharmaceuticals IncMDGL | 4 | Strong Buy | $336.00 | +122.61% | Reiterates | 2 months ago |
Theratechnologies IncTHTX | 4 | Hold | $8.00 | +283.14% | Assumes | 3 months ago |
Dice Therapeutics IncDICE | 3 | Hold | $48.00 | +0.95% | Downgrades | 3 months ago |
Cardiol Therapeutics IncCRDL | 2 | Strong Buy | $6.00 | +569.64% | Maintains | 4 months ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $48.00 | +229.22% | Initiates Coverage On | 4 months ago |
Akero Therapeutics IncAKRO | 3 | Strong Buy | $59.00 | +30.07% | Maintains | 4 months ago |
Oramed Pharmaceuticals IncORMP | 2 | Hold | $2.00 | -22.78% | Maintains | 4 months ago |
Ventyx Biosciences IncVTYX | 3 | Strong Buy | $54.00 | +59.43% | Maintains | 8 months ago |
Amryt Pharma PLCAMYT | 2 | Hold | $17.00 | +15.65% | Downgrades | 9 months ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | $15.00 | N/A | Downgrades | a year ago |
Chemocentryx IncCCXI | 2 | Hold | $52.00 | N/A | Downgrades | a year ago |
Rezolute IncRZLT | 1 | Strong Buy | $17.00 | N/A | Assumes | a year ago |
Obseva SaOBSVF | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Morphic Holding IncMORF | 1 | Strong Buy | $68.00 | N/A | Initiates Coverage On | a year ago |
Metacrine IncMTCR | 1 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Adverum Biotechnologies IncADVM | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $54.00 | N/A | Maintains | 5 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Uniqure NvQURE | 1 | Strong Buy | $48.00 | N/A | Initiates Coverage On | 5 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $650.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.